144 related articles for article (PubMed ID: 1288420)
1. Anticentromere-protein-B--DNA complex activities in anticentromere antibody-positive patients.
Muro Y; Matsumoto Y; Ohashi M
Arch Dermatol Res; 1992; 284(7):396-9. PubMed ID: 1288420
[TBL] [Abstract][Full Text] [Related]
2. Anticentromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen.
Vázquez-Abad D; Wallace S; Senécal JL; Joyal F; Roussin A; Earnshaw WC; Rothfield N
Arthritis Rheum; 1994 Feb; 37(2):248-52. PubMed ID: 8129780
[TBL] [Abstract][Full Text] [Related]
3. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
4. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
Kremer L; Alvaro-Gracia JM; Ossorio C; Avila J
Clin Exp Immunol; 1988 Jun; 72(3):465-9. PubMed ID: 3048807
[TBL] [Abstract][Full Text] [Related]
5. Purification of a human centromere antigen (CENP-B) and application of DNA immunoprecipitation to quantitative assay for anti-CENP-B antibodies.
Muro Y; Masumoto H; Okazaki T; Ohashi M
J Invest Dermatol; 1991 Aug; 97(2):378-80. PubMed ID: 2071944
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal study of anticentromere and antitopoisomerase-I isotypes.
Vázquez-Abad D; Russell CA; Cusick SM; Earnshaw WC; Rothfield NF
Clin Immunol Immunopathol; 1995 Mar; 74(3):257-70. PubMed ID: 7859416
[TBL] [Abstract][Full Text] [Related]
7. Idiotypic analysis of human anticentromere autoantibodies.
Hildebrandt S; Weiner ES; Earnshaw WC; Zanetti M; Rothfield NF
Autoimmunity; 1991; 9(2):131-40. PubMed ID: 1657226
[TBL] [Abstract][Full Text] [Related]
8. Frequency of autoantibodies to a major epitope on the carboxyl terminal fragment of CENP-B in patients with autoimmune disease.
Whyte J; Soriano E; Earnshaw WC; McHugh NJ
Br J Rheumatol; 1995 May; 34(5):407-12. PubMed ID: 7788167
[TBL] [Abstract][Full Text] [Related]
9. The clinical expression in anticentromere antibody-positive patients is not specified by the epitope recognition of CENP-B antigen.
Muro Y; Sugimoto K; Himeno M; Ohashi M
J Dermatol; 1992 Oct; 19(10):584-91. PubMed ID: 1283396
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities.
Parveen S; Morshed SA; Nishioka M
J Gastroenterol Hepatol; 1995; 10(4):438-45. PubMed ID: 8527711
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F
J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261
[TBL] [Abstract][Full Text] [Related]
12. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
[TBL] [Abstract][Full Text] [Related]
13. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
[TBL] [Abstract][Full Text] [Related]
14. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies.
Jabs EW; Tuck-Muller CM; Anhalt GJ; Earnshaw W; Wise RA; Wigley F
Cytogenet Cell Genet; 1993; 63(3):169-75. PubMed ID: 8387418
[TBL] [Abstract][Full Text] [Related]
16. Anticentromere antibodies in subjects with no apparent connective tissue disease.
Lee SL; Tsay GJ; Tsai RT
Ann Rheum Dis; 1993 Aug; 52(8):586-9. PubMed ID: 8215621
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to centromere antigens measured by an automated enzyme immunoassay.
González-Buitrago JM; González C; Hernando M; Carrasco R; Sánchez A; Navajo JA; Papisch W
Clin Chim Acta; 2003 Feb; 328(1-2):135-8. PubMed ID: 12559609
[TBL] [Abstract][Full Text] [Related]
18. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
[TBL] [Abstract][Full Text] [Related]
20. Anticentromere antibody-positive primary Sjögren's syndrome: Epitope analysis of a subset of anticentromere antibody-positive patients.
Tanaka N; Muro Y; Suzuki Y; Nishiyama S; Takada K; Sekiguchi M; Hashimoto N; Ohmura K; Shimoyama K; Saito I; Kawano M; Akiyama M
Mod Rheumatol; 2017 Jan; 27(1):115-121. PubMed ID: 27161330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
